Scroll Top

Quironsalud (qs)


Brief Biography of Partner

Quirónsalud is the leading hospital group in Spain. As part of the firm’s parent company Fresenius-Helios, Quirónsalud also belongs to Europe’s largest family of hospitals. Outside of Spain, Quirónsalud also operates in Latin America, particularly Colombia and Peru. The group has a total headcount of over 45,000 employees who work in more than 180 health centres, 58 of which are hospital facilities totaling 8,000 beds. Quirónsalud’s patients receive care that combines state-of-the-art technology with highly specialised, internationally renowned staff.

The Quirónsalud group strives to promote teaching, and nine of its hospitals have a university affiliation. Medical and scientific research is also a priority for the company, led by the Health Research Institute – Fundación Jiménez Díaz. Quirónsalud care services operate as interdisciplinary units and networks, allowing local expertise from its various health centres to be shared throughout the network, maximising clinical translation of the group’s research findings. Quirónsalud is currently conducting numerous research projects across the country, and many of its health centers are engaged in additional cutting-edge investigation efforts, particularly in the fields of oncology, cardiology, endocrinology, gynecology, and neurology, among others.

Partner’s Role in the SUNRISE project

Within SUNRISE, Quironsalud will take part in the project’s Spanish cluster whose aim is to provide a framework for understanding the specific functioning of the critical infrastructures and cooperation amongst their operators in Spain.

Additionally, Quirónsalud, as a health infrastructure, will participate in the development of the SUNRISE technical tool for ‘Demand Prediction and Management’ that will focus on managing the changing demand of critical infrastructures resources (both human and infrastructure) due to pandemics.